Scaling AI Safely Will Define Success for Healthcare Leaders in 2026
Rhea-AI Summary
Kyndryl (NYSE: KD) released its 2025 Healthcare Readiness Report on March 5, 2026, finding a large gap between AI ambition and safe, scalable adoption in healthcare. Key metrics: 76% report more AI pilots than they can scale, 55% worry about keeping pace with regulation, 30% feel prepared, 31% cite regulatory barriers.
Kyndryl launched a policy as code capability and named collaborations with Servei de Salut de les Illes Balear and University of Liverpool CHIL to advance trusted, auditable AI in clinical environments.
Positive
- Launched policy as code capability to convert rules into machine-readable policies
- Named collaboration with Servei de Salut de les Illes Balear for clinical-genomic AI platform
- Collaboration with University of Liverpool CHIL to apply Agentic AI Framework
Negative
- 76% of healthcare organizations report more AI pilots than they can scale
- 55% of healthcare organizations are concerned about keeping pace with regulation
- Only 30% of healthcare organizations feel prepared to adapt to evolving policy
- 31% cite regulatory and compliance concerns as a key barrier to scaling AI
News Market Reaction – KD
On the day this news was published, KD gained 2.82%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
KD is up 2.26% with mixed peers: most key comps like G, EPAM, EXLS and GDS modestly positive, while PSN is negative. No peers show momentum scanner flags, suggesting the move is more company-specific than sector-driven.
Previous AI Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 24 | Healthcare AI collaboration | Positive | +2.1% | Teamed with University of Liverpool to co-develop healthcare AI blueprints. |
| Feb 16 | AI skilling initiative | Positive | +11.0% | Expanded AI education and skilling programs tied to a large India commitment. |
| Feb 11 | AI governance launch | Positive | +9.0% | Introduced policy-as-code to govern agentic AI in regulated environments. |
| Jan 27 | SAP AI CoE | Positive | -2.5% | Established SAP Center of Excellence for agentic AI-driven transformations. |
| Jan 21 | SAP AI modernization | Positive | +1.1% | Unveiled Clean Field approach using agentic AI for SAP migrations. |
AI-related announcements have usually been followed by positive next-day moves, with one notable negative divergence.
Over recent months, Kyndryl has repeatedly highlighted its AI strategy. On Jan 21 and Jan 27, it introduced agentic AI approaches for SAP modernization. On Feb 11, it unveiled policy-as-code governance for mission-critical AI, followed by AI skilling initiatives in India on Feb 16 and a healthcare-focused Agentic AI collaboration on Feb 24. Today’s healthcare AI governance report extends this AI narrative into regulated clinical settings, consistent with the company’s focus on trusted, scalable AI deployment.
Historical Comparison
In the past months, KD’s AI-tagged releases moved an average of 4.13% the next day. Today’s 2.26% gain on a healthcare AI governance update sits within that historical range.
AI news has progressed from SAP modernization and governance to broader skilling programs and healthcare-focused agentic AI collaborations, showing a widening application of its AI framework.
Market Pulse Summary
This announcement highlights Kyndryl’s push to make AI in healthcare safer and more compliant, emphasizing policy-as-code governance and real-world collaborations. It builds on prior AI initiatives in workflow governance, SAP modernization and healthcare partnerships. Investors may track how many healthcare customers adopt these capabilities, whether pilot projects transition into scaled deployments, and how AI-related offerings contribute alongside existing services, while also monitoring broader financial performance and regulatory disclosures for execution risks.
Key Terms
ai technical
policy as code technical
agentic ai technical
clinical‑genomic analysis medical
AI-generated analysis. Not financial advice.
Kyndryl Readiness Report: Healthcare organizations that modernize and strengthen AI governance will be equipped to meet regulatory demands and patient care expectations
The healthcare industry report shows a widening gap between healthcare organizations' ambition to adopt AI and their ability to scale it safely and compliantly. In fact, more than half (
To help healthcare organizations move from AI experimentation to trusted, scalable AI, Kyndryl recently launched its policy as code capability, which converts regulatory requirements and operational controls into machine‑readable policies. These policies govern how agentic AI workflows operate, enabling consistent enforcement, auditability and trust as AI is embedded into clinical and operational environments.
"Healthcare organizations are operating in one of the most complex regulatory environments in the world, and as AI becomes embedded into clinical and operational workflows, compliance can't be an afterthought. Our policy as code capability allows healthcare providers to translate regulatory, security, and organizational policies directly into their digital and AI systems," said Christine Landry, Global Vice President for Healthcare, Kyndryl Consult. "Enabling these guardrails not only helps ensure consistence compliance but also strengthens resilience by reducing operational risk and helping systems withstand evolving cyber and privacy threats. This gives clinicians and administrators greater confidence that compliance, safety, governance and protections are built in from the start, not bolted on later."
Kyndryl is working with healthcare organizations globally to modernize operations and support responsible AI adoption. For example, Servei de Salut de les Illes Balear (the Balearic Islands Health Service) is collaborating with Kyndryl to develop an AI‑enabled platform that supports advanced clinical‑genomic analysis, helping accelerate diagnosis while aligning with their security and data protection requirements.
Kyndryl also recently announced a collaboration with the University of
For more insights, view the full 2025 Healthcare Readiness Report.
About Kyndryl
Kyndryl (NYSE: KD) is a leading provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to thousands of customers in more than 60 countries. As the world's largest IT infrastructure services provider, the company designs, builds, manages and modernizes the complex information systems that the world depends on every day. For more information, visit www.kyndryl.com.
Kyndryl press contact
press@kyndryl.com
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements often contain words such as "aim," "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "may," "objectives," "opportunity," "plan," "position," "predict," "project," "should," "seek," "target," "will," "would" and other similar words or expressions or the negative thereof or other variations thereon. All statements other than statements of historical fact, including without limitation statements concerning the Company's plans, objectives, goals, beliefs, business strategies, future events, business condition, results of operations, financial position, business outlook and business trends and other non-historical statements, are forward-looking statements. These statements do not guarantee future performance and speak only as of the date of this press release. Except as required by law, the Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual outcomes or results may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties, including those described in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K and quarterly report on Form 10-Q for the quarter ended December 31, 2025, and may be further updated from time to time in the Company's subsequent filings with the Securities and Exchange Commission.
View original content to download multimedia:https://www.prnewswire.com/news-releases/scaling-ai-safely-will-define-success-for-healthcare-leaders-in-2026-302705370.html
SOURCE Kyndryl
FAQ
What did Kyndryl (KD) report about healthcare organizations' AI readiness on March 5, 2026?
What is Kyndryl's policy as code capability and how does it help healthcare (KD)?
How do regulatory concerns affect AI scaling in healthcare, per Kyndryl's report (KD)?
What partnerships did Kyndryl (KD) announce to advance healthcare AI adoption?
How might Kyndryl's work impact clinical-genomic analysis for healthcare providers (KD)?
